• Forum
  • Stock Markets
    • MarketsLive prices, indices, and market performance
    • Stock CalendarUpcoming earnings, listings, and corporate events
    • Dividends CalendarFuture and past dividends
  • Companies
    • CompaniesBrowse and filter the full list of listed companies
    • DiscoveryInspiration for your next investment
    • IPOsNew listings and upcoming public offerings
    • AGM InvitationsAnnual general meeting dates and shareholder info
  • Stock Research
    • ResearchExpert stock analysis and recommendations
    • ArticlesNews, insights, and market commentary
    • inderesTVVideo hub for stock research, analysis, and expert commentary
    • TranscriptsFull text records of earnings calls and investor meetings
    • Stock ComparisonCompare financials and performance across multiple stocks
Find us on social media
  • Inderes Forum
  • Youtube
  • Facebook
  • X (Twitter)
Get in touch
  • info@hcandersencapital.dk
  • Bredgade 23B, 2. sal
    1260 København K
Inderes
  • About us
  • Our team
  • Careers
  • Inderes as an investment
  • Services for listed companies
Our platform
  • FAQ
  • Terms of service
  • Privacy policy
  • Disclaimer

Inderes’ Disclaimer can be found here. Detailed information about each share actively monitored by Inderes is available on the company-specific pages on Inderes’ website. © Inderes Oyj. All rights reserved.

Calliditas Therapeutics

Less than 1K followers
All
Webcasts
Press releases
ShowingAll content types

Regulatory press release9/30/2024, 12:30 PM

Bulletin from the extraordinary general meeting of Calliditas Therapeutics AB (publ)

Calliditas Therapeutics
Regulatory press release9/16/2024, 1:30 PM

Delisting of Calliditas Therapeutics AB (publ) from Nasdaq Stockholm

Calliditas Therapeutics
Regulatory press release9/3/2024, 10:15 AM

Calliditas Therapeutics takes certain corporate actions following announcement by Asahi Kasei

Calliditas Therapeutics

Join Inderes community

Don't miss out - create an account and get all the possible benefits

Inderes account
Followings and notifications on followed companies
Analyst comments and recommendations
Stock comparison tool & other popular tools
Create account
Regulatory press release9/3/2024, 10:00 AM

Notice of extraordinary meeting of Calliditas Therapeutics AB (publ)

Calliditas Therapeutics
Press release8/15/2024, 9:45 AM

Redeye: Calliditas Update - The Final Countdown

Calliditas Therapeutics
Calliditas Therapeutics, Audiocast with teleconference, Q2'24
Webcast8/13/2024, 12:30 PM

Calliditas Therapeutics, Audiocast with teleconference, Q2'24

Calliditas Therapeutics
Regulatory press release8/13/2024, 5:00 AM

Calliditas Therapeutics: Calliditas Interim Report January to June 2024

Calliditas Therapeutics
Press release8/5/2024, 5:00 AM

Calliditas Therapeutics: Invitation to the presentation of Calliditas's interim report January - June 2024

Calliditas Therapeutics
Regulatory press release7/31/2024, 12:00 PM

Number of shares and votes in Calliditas Therapeutics

Calliditas Therapeutics
Press release7/26/2024, 3:00 PM

Calliditas Therapeutics: Calliditas partner STADA receives European Commission decision for full approval of Kinpeygo® for the treatment of IgA Nephropathy

Calliditas Therapeutics
Regulatory press release7/26/2024, 6:00 AM

Calliditas Therapeutics: Calliditas announces positive TRANSFORM Phase 2b topline data in primary biliary cholangitis

Calliditas Therapeutics
Press release7/4/2024, 6:30 AM

Calliditas Therapeutics: Launch of Phase 3 clinical trial with Nefecon in Japan

Calliditas Therapeutics
Press release6/18/2024, 10:15 AM

Calliditas Therapeutics: Calliditas provides setanaxib patent update

Calliditas Therapeutics
Regulatory press release6/17/2024, 3:30 PM

Bulletin from the annual general meeting of Calliditas Therapeutics AB (publ)

Calliditas Therapeutics
Regulatory press release5/30/2024, 6:00 PM

Calliditas Therapeutics: Calliditas partner STADA receives positive CHMP opinion recommending full approval for Kinpeygo[®] for the treatment of IgA nephropathy

Calliditas Therapeutics
Calliditas Therapeutics R&D Day, 2024
Webcast5/30/2024, 1:00 PM

Calliditas Therapeutics R&D Day, 2024

Calliditas Therapeutics
Press release5/28/2024, 12:00 PM

Calliditas Therapeutics Presents Data at the 61[st] European Renal Association Congress

Calliditas Therapeutics
Regulatory press release5/28/2024, 6:30 AM

Statement by the Board of Directors of Calliditas Therapeutics AB (publ) in relation to the public offer by Asahi Kasei Corporation

Calliditas Therapeutics
Press release5/24/2024, 5:11 AM

Redeye: Calliditas Q1 - Powerful launch momentum

Calliditas Therapeutics
Calliditas Therapeutics, Audiocast with teleconference, Q1'24
Webcast5/23/2024, 12:30 PM

Calliditas Therapeutics, Audiocast with teleconference, Q1'24

Calliditas Therapeutics